{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:21:45Z","timestamp":1762078905594},"reference-count":31,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2006,7,17]],"date-time":"2006-07-17T00:00:00Z","timestamp":1153094400000},"content-version":"vor","delay-in-days":5968,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[1990,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Suramin, a drug used in the treatment of trypanosomiasis and onchocerciasis inhibits growth\u2010factor\u2010induced mitogenesis. We have investigated the effect of suramin on the growth rate and the morphology of C6 glioma cells cultured in the presence of serum or in a serum\u2010free defined medium. Exponentially growing cells were seeded in multi\u2010dish plates (5 \u00d7 10<jats:sup>4<\/jats:sup> cells\/2 cm<jats:sup>2<\/jats:sup> well) in DMEM supplemented with 5% fetal calf serum and were continuously exposed to 1 \u03bcg\/ml to 1,000 \u03bcg\/ml suramin. Growth rate (determined 9 days after seeding) was reduced by 5%, 33%, 56% and 97%, respectively for suramin concentrations of 1, 10, 100 and 1000 \u03bcg\/ml. Similar results were obtained in serum\u2010free defined medium (DMEM\/F12, 1:1, v:v, EGF 5 ng\/ml, transferrin 5 \u03bcg\/ml, selenium 10 ng\/ml). Moreover, the concentration of suramin in the culture medium remained constant, demonstrating that the drug was not actively metabolized by the cells. Suramin also induced marked changes in cell morphology: the usual bipolar shape of C6 cells evolved toward a more differentiated appearance, with numerous cellular processes allowing a wide number of cell\u2010cell contacts. In parallel, we monitored expression of an adhesion molecule (N\u2010CAM) at both the mRNA and protein levels. Indirect immunofluorescence technique showed an important increase in cell surface N\u2010CAM expression, starting from a dose of 10 \u03bcg\/ml suramin, whereas total cellular content of N\u2010CAM protein as well as its mRNA levels were unaffected. We also observed that the levels of expression of actin and N\u2010CAM mRNAs decreased by a factor of two in cells maintained in defined medium. However, the relative ratio of N\u2010CAM mRNA over actin mRNA was virtually unchanged following suramin treatment. Taken together, our results suggest that suramin (i) exerts a blocking effect of autocrine growth factors, (ii) interferes with the turn\u2010over mechanisms of N\u2010CAM expressed at the cell surface, either by impairing its endocytosis and\/or the process of release of the N\u2010CAM 120 isoform.<\/jats:p>","DOI":"10.1002\/ijc.2910450330","type":"journal-article","created":{"date-parts":[[2007,2,19]],"date-time":"2007-02-19T21:58:48Z","timestamp":1171922328000},"page":"554-561","source":"Crossref","is-referenced-by-count":38,"title":["Suramin inhibits proliferation of rat glioma cells and alters N\u2010cam cell surface expression"],"prefix":"10.1002","volume":"45","author":[{"given":"Jacques","family":"Fantini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao\u2010Jun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Marvaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevi\u00e8ve","family":"Rougon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,17]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1987.tb04837.x"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.17.6440"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)90002-9"},{"key":"e_1_2_1_5_1","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1001\/jama.1987.03400100081025","article-title":"Suramin therapy in AIDS and related disorders. Report of the US suramin working group","volume":"258","author":"Cheson B. D.","year":"1987","journal-title":"J. amer. Med. Assoc."},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(87)90021-2"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.1041320120"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910420618"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)81797-5"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(84)90381-6"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.57.070188.001441"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.06-07-01983.1986"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1985.tb03676.x"},{"key":"e_1_2_1_14_1","first-page":"121","article-title":"Comparisons of carmustine, procarbazine, and high\u2010dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma","volume":"67","author":"Green S. B.","year":"1983","journal-title":"Cancer Treat. Rep."},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1054-3589(08)60486-X"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1986.tb04526.x"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.105.6.2489"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.240290310"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-68-8-2183"},{"key":"e_1_2_1_20_1","first-page":"559","article-title":"Therapeutic efficacy of antiglioma mesenchymal extracellular matrix 131\u2010I\u2010radiolabeled murine monoclonal antibody in a human glioma xenograft model","volume":"48","author":"Lee Y. S.","year":"1988","journal-title":"Cancer Res."},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.490070212"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.6091268"},{"key":"e_1_2_1_23_1","first-page":"3910","article-title":"Expression of messenger RNAs for platelet\u2010derived growth factor and transforming growth factor\u2010alpha and their receptors in human malignant glioma cell lines","volume":"48","author":"Nister M.","year":"1988","journal-title":"Cancer Res."},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1982.tb00019.x"},{"key":"e_1_2_1_25_1","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1016\/S0021-9258(17)35796-4","article-title":"Structural and immunological characterization of the amino\u2010terminal domain of mammalian neural cell adhesion molecules","volume":"261","author":"Rougon G.","year":"1986","journal-title":"J. biol. Chem."},{"key":"e_1_2_1_26_1","first-page":"3617","article-title":"Antiproliferative effect of verapamil alone on brain tumor cells in vitro","volume":"48","author":"Schmidt W. F.","year":"1988","journal-title":"Cancer Res."},{"key":"e_1_2_1_27_1","first-page":"4694","article-title":"Antiproliferative effects of suramin on lymphoid cells","volume":"47","author":"Spigelman Z.","year":"1987","journal-title":"Cancer Res."},{"key":"e_1_2_1_28_1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1200\/JCO.1989.7.4.499","article-title":"Suramin: an anti\u2010cancer drug with a unique mechanism of action","volume":"7","author":"Stein C. A.","year":"1988","journal-title":"J. clin. Oncol."},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0731-7085(89)80073-1"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(89)91013-5"},{"key":"e_1_2_1_31_1","first-page":"152","article-title":"Initiation of primary cell cultures from human intracranial tumors on extracellular matrix from bovine corneal endothelial cells","volume":"55","author":"Westphal M.","year":"1987","journal-title":"Exp. Cell Biol."},{"key":"e_1_2_1_32_1","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1016\/S0021-9258(17)42987-5","article-title":"Platelet\u2010derived growth factor receptors form a high affinity state in membrane preparations. Kinetics and affinity cross\u2010linking studies","volume":"259","author":"Williams L. T.","year":"1984","journal-title":"J. biol. Chem."}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.2910450330","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.2910450330","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T01:40:31Z","timestamp":1698025231000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.2910450330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,3,15]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1990,3,15]]}},"alternative-id":["10.1002\/ijc.2910450330"],"URL":"https:\/\/doi.org\/10.1002\/ijc.2910450330","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,3,15]]}}}